Humacyte, Inc. (HUMA) Misses Q3 EPS by 2c

Humacyte, Inc. (NASDAQ: HUMA) reported Q3 EPS of ($0.25), $0.02 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $30 thousand versus the consensus estimate of $236.02 thousand.

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says
• Piper Sandler picks Q2 Holdings as preferred stock in payments coverage